| Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics R Garcıa-Sanz, A Orfao, M Gonzalez, MD Tabernero, J Bladé, MJ Moro, ... Blood, The Journal of the American Society of Hematology 93 (3), 1032-1037, 1999 | 443 | 1999 |
| Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research S Arai, M Arora, T Wang, SR Spellman, W He, DR Couriel, ... Biology of Blood and Marrow Transplantation 21 (2), 266-274, 2015 | 390 | 2015 |
| The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes S Tabera, JA Pérez-Simón, M Díez-Campelo, LI Sánchez-Abarca, ... haematologica 93 (9), 1301-1309, 2008 | 358 | 2008 |
| A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed … L Rosiñol, JA Pérez-Simón, A Sureda, J de la Rubia, F de Arriba, ... Blood, The Journal of the American Society of Hematology 112 (9), 3591-3593, 2008 | 307 | 2008 |
| Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic … D Valcárcel, R Martino, D Caballero, J Martin, C Ferra, JB Nieto, ... Journal of Clinical Oncology 26 (4), 577-584, 2008 | 262 | 2008 |
| Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders JA Pérez-Simón, PD Kottaridis, R Martino, C Craddock, D Caballero, ... Blood, The Journal of the American Society of Hematology 100 (9), 3121-3127, 2002 | 262 | 2002 |
| Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines B Blanco, JA Pérez-Simón, LI Sánchez-Abarca, X Carvajal-Vergara, ... Blood 107 (9), 3575-3583, 2006 | 247 | 2006 |
| Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting LI Sánchez-Abarca, S Gutierrez-Cosio, C Santamaría, ... Blood, The Journal of the American Society of Hematology 115 (1), 107-121, 2010 | 242 | 2010 |
| Prognostic value of numerical chromosome aberrations in multiple myeloma: a FISH analysis of 15 different chromosomes JA Perez-Simon, R Garcıa-Sanz, MD Tabernero, J Almeida, M Gonzalez, ... Blood, The Journal of the American Society of Hematology 91 (9), 3366-3371, 1998 | 217 | 1998 |
| Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool J Garcia‐Castro, C Trigueros, J Madrenas, JA Perez‐Simon, R Rodriguez, ... Journal of cellular and molecular medicine 12 (6b), 2552-2565, 2008 | 214 | 2008 |
| Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and … R Martino, MD Caballero, JA Pérez Simón, C Canals, C Solano, ... Blood, The Journal of the American Society of Hematology 100 (6), 2243-2245, 2002 | 210 | 2002 |
| Vitamin D: effect on haematopoiesis and immune system and clinical applications M Medrano, E Carrillo-Cruz, I Montero, JA Perez-Simon International journal of molecular sciences 19 (9), 2663, 2018 | 200 | 2018 |
| Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial JA Pérez-Simon, O López-Villar, EJ Andreu, J Rifón, S Muntion, ... haematologica 96 (7), 1072, 2011 | 198 | 2011 |
| Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled … M Aguilar-Guisado, I Espigado, A Martín-Peña, C Gudiol, ... The Lancet Haematology 4 (12), e573-e583, 2017 | 190 | 2017 |
| Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial NH Fowler, M Dickinson, M Dreyling, J Martinez-Lopez, A Kolstad, ... Nature medicine 28 (2), 325-332, 2022 | 189 | 2022 |
| Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation EM Villaron, J Almeida, N López-Holgado, M Alcoceba, ... Haematologica 89 (12), 1421-1427, 2004 | 187 | 2004 |
| Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q− syndrome O Lopez-Villar, JL Garcia, FM Sanchez-Guijo, C Robledo, EM Villarón, ... Leukemia 23 (4), 664-672, 2009 | 179 | 2009 |
| Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft‐versus‐host disease after allogeneic transplantation JA Pérez‐Simón, M Díez‐Campelo, R Martino, S Brunet, Á Urbano, ... British journal of haematology 130 (3), 394-403, 2005 | 145 | 2005 |
| Are myeloma patients with renal failure candidates for autologous stem cell transplantation? JF San Miguel, JJ Lahuerta, R Garcia-Sanz, A Alegre, J Blade, R Martinez, ... The Hematology Journal: the Official Journal of the European Haematology …, 2000 | 136 | 2000 |
| International Myeloma Working Group consensus statement regarding the current status of allogeneic stem-cell transplantation for multiple myeloma H Lokhorst, H Einsele, D Vesole, B Bruno, JS Miguel, JA Pérez-Simon, ... Journal of Clinical Oncology 28 (29), 4521-4530, 2010 | 134 | 2010 |
Teresa Caballero VelázquezProfesor Contratado Doctor (Plaza Vinc.)Verified email at us.es
